根据需要在喘中吸入皮质类固醇:从证据到实施
Eric Merrell1,2, Sandhya Khurana1,2
1Pulmonary & Critical Care Division, University of Rochester Medical Center.
Current opinion in pulmonary medicine
|February 24, 2026
概括
现在首选的喘治疗方法是根据需要吸入皮质类固醇 (ICS) 与快速起作用的支气管扩展剂,取代短效β激动剂 (SABA) 单疗法. 这种吸入性皮质类固醇策略的实施在美国面临挑战.
科学领域:
- 肺部病理学 肺部病理学
- 药理学 药理学是指药理学的学科.
- 喘管理 喘管理
背景情况:
- 最近的指导方针建议吸入性皮质类固醇 (ICS) 与快速起作用的支气管扩展剂作为首选的喘治疗方法.
- 短效β激动剂 (SABA) 单一治疗不再被推用于喘管理.
- 美国食品和药物管理局 (FDA) 最近批准了一种新的ICS/SABA组合吸入器.
研究的目的:
- 为了澄清在成年人喘严重程度上所需的ICS的作用.
- 探索基于ICS的喘管理的实施挑战.
- 审查最近FDA批准ICS/SABA吸入器的影响.
主要方法:
- 对当前喘指南和治疗策略的文献综述.
- 对GINA和NHLBI最近的建议进行分析.
- 探索实施新的喘治疗模式的障碍和促进因素.
主要成果:
- 全球喘倡议 (GINA) 和美国国家心脏,肺和血液研究所 (NHLBI) 的指导方针现在支持基于ICS的策略.
- 建议使用ICS/formoterol进行维持和缓解疗法 (MART).
- 尽管有建议,但这些ICS战略在美国的采用速度很慢,并发现了实施障碍.
结论:
- 针对MART的单个ICS/formoterol吸入器比传统的多吸入器方案提供了潜在的多领域优势.
- 新的ICS/SABA组合吸入器的临床实用性需要在喘谱中进一步调查.
- 优化ICS使用对于改善喘控制和患者结果至关重要.
相关概念视频
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
1.7K
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
1.7K
01:23Inhaled Medications
899
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
899
01:26COPD: Management Using Bronchodilators and Corticosteroids
942
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
942
01:30Asthma-IV: Diagnostic and Management
3.2K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.2K
01:17Drugs Used in Lower Respiratory Disorders: Overview
1.3K
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
1.3K
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
2.0K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
2.0K